Zimbabwe has declined a substantial US healthcare agreement worth 367 million US dollars (£272m) spanning five years due to the United States' request for confidential information.
This rejection became public after a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".
An official representative later stated that the United States was demanding access to genetic material for scientific study and commercial gain but was unwilling to guarantee the resulting advantages from future treatments.
"We will now turn to the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for continued talks to find a agreement acceptable to both sides so the nation's critical HIV treatment initiative can proceed.
Wider Implications
This development comes after a similar case in neighbouring Kenya, where a high court halted a related health funding agreement after concerns were filed about the security of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had overseen aid for the US government, but Trump stated its spending was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and accountability.
According to statements, Sixteen African countries have so far signed these new agreements, constituting over $18.3bn of fresh investment.
Details of the Declined Agreement
The funds for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy via US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any equivalent assurance of access to any medical innovations – like new medicines or tests – that might result from that shared data," his statement read.
"Put simply, our nation would supply the raw materials for scientific discovery without any assurance that the final treatments would be accessible to our people should a new health crisis arise."
Sovereignty and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending systems previously established via the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing system created to manage potential pandemics.
"This framework is intended to ensure that when a country provides its information, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to continued dialogue with our US partners on how subsequent collaboration could be structured in a way that honours the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that talks must proceed considering a large portion of the nation's Aids initiatives relied on international support.
"If specific concerns exist, including those relating to data governance or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," the group said.
The halted deal highlights the ongoing tensions between accepting vital international aid and safeguarding a country's data in an increasingly interconnected world.